Pharmx Technologies (ASX:PHX) — Material Events
ASX:PHX · 5 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Pharmx and Sigma Forge Strategic Alliance with Equity and Board SeatHigh
Pharmx and Sigma form multi-year strategic alliance with equity stake and board seat
23 Feb 2026
·Strategic Alliance Announcement
·85
Pharmx Posts Record $7.5M Revenue Amid Strategic Growth PushMedium
Pharmx reports record revenue growth and strategic investments, positioning for future expansion
20 Aug 2025
·Annual Financial Results
·85
Pharmx Delivers 13% Revenue Growth and Positive EBITDA Amid Platform ExpansionMedium
Pharmx FY25 revenue up 13%, positive EBITDA, strong cash, and growth strategy for FY26
20 Aug 2025
·Investor Presentation
·85
Pharmx Advances Platform Amid Losses, Seals Strategic Alliance with Sigma HealthcareMedium
Pharmx reports H1 FY26 revenue growth but posts net loss amid strategic investments; announces Sigma alliance
25 Feb 2026
·Half Year Financial Report
·80
Pharmx Accelerates Revenue Growth Amid Strategic Tech InvestmentsMedium
Pharmx reports 13% revenue growth but profit dips amid strategic tech investments
20 Aug 2025
·Appendix 4E and Annual Report
·75
No articles in this tier for the last 12 months.
Market Mentions
3
- appeared in market wrap coverage
These are market wrap articles where Pharmx Technologies (ASX:PHX) was mentioned. They reflect broader market coverage, not company-specific announcements.
Market Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Technology Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026